DLHL
BIIB icon

Donald L. Hagan LLC’s Biogen BIIB Stock Holding History

Donald L. Hagan LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-80
Closed -$21K – 116
2016
Q1 		$21K Buy
+80
New +$21.1K 0.02% 198
2015
Q4 		– Sell
-40
Closed -$12K – 103
2015
Q3 		$12K Buy
+40
New +$13.2K 0.01% 265

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Donald L. Hagan LLC's BIIB Position: Q2 2016 in Review

Donald L. Hagan LLC sold out of Biogen (BIIB) in Q2 2016, closing a stake of 80 shares — an estimated $21K sold.

Donald L. Hagan LLC first reported a position in BIIB in Q3 2015 and held it in 2 quarters. The position peaked at $21K in Q1 2016. 967 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

  • Donald L. Hagan LLC reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 80 Biogen shares in Q2 2016, an estimated $21K.
  • Donald L. Hagan LLC first reported a position in Biogen in Q3 2015 and held it in 2 quarters.
  • Donald L. Hagan LLC's Biogen position peaked at $21K in Q1 2016.
  • 967 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Donald L. Hagan LLC's 13F filing for Q2 2016, filed 21 Jul 2016.